MetaCap

Elanco Animal Health Insider Trades

NYSE: ELANHealth CareBiotechnology: Pharmaceutical PreparationsUSD

22.92+0.38 (+1.69%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

After hours: 22.92 +0.02%

Last 12 months

Purchases
5 · $1.47M
Sales
0 · $0
Shares bought / sold
63.20K / 0
Net activity
Net buying $1.5 million

Elanco Animal Health insider activity

Over the last 12 months, Elanco Animal Health insiders reported 10 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $1.5 million and sold $0 worth of stock, for net insider buying of $1.5 million. The most recent filing shows Kurzius Lawrence Erik (Director) buying 40,000 shares at $23.40 on Aug 20, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ELAN's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

ELAN insider transactions

Elanco Animal Health insider transactions
DateInsiderTypeSharesValueFiling
Aug 20, 2026Kurzius Lawrence ErikDirectorBuy40,000$935.92KForm 4
Aug 18, 2026O'Neill ShivGC AND CORP SECBuy3,998$94.27KForm 4
Aug 12, 2026Harrington Michael JDirectorBuy5,000$109.10KForm 4
Aug 7, 2026Herendeen PaulDirectorBuy10,000$236.85KForm 4
Aug 7, 2026VanHimbergen Robert MEVP and CFOBuy4,200$96.93KForm 4
Jul 7, 2026VanHimbergen Robert MEVP and CFOTax withholding15,336$377.88KForm 4
May 21, 2026Kurzius Lawrence ErikDirectorAward12,196—Form 4
May 21, 2026Kurzius Lawrence ErikDirectorAward4,678—Form 4
May 21, 2026Scots-Knight DeniseDirectorAward12,196—Form 4
May 21, 2026Scots-Knight DeniseDirectorAward4,678—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related